∆F13L-GFP-Vac (p37-deleted vaccinia virus) is attenuated in mice and protects against infection with wild-type virus

Inge Vliegen; Guang Yang; Dennis E. Hruby; De Clercq Erik; Robert Jordan; Johan Neyts

Related publications

Article2006

Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice

Graciela Andreï, Don B. Gammon, Pierre Fiten, De Clercq Erik, Ghislain Opdenakker, Robert Snoeck, David H. Evans

Article1986

Xylotubercidin against herpes simplex virus type 2 in mice

De Clercq Erik, M. J. ROBINS

Article2010

Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity

Ya‐Jen Chang, Hye Young Kim, Lee A. Albacker, Hyun Hee Lee, Nicole Baumgarth, Akira Shizuo, Paul B. Savage, Shin Endo, Takashi Yamamura, Janneke J. Maaskant, Naoki Kitano, Abel Singh, Apoorva Bhatt, Gurdyal S. Besra, Peter van den Elzen, Ben J. Appelmelk, Richard W. Franck, Guangwu Chen, Rosemarie H. DeKruyff, Michio Shimamura, Petr A. Illarionov, Dale T. Umetsu

Journal of Clinical Investigation

Article2012

Muramyl Dipeptide Induces NOD2-Dependent Ly6Chigh Monocyte Recruitment to the Lungs and Protects Against Influenza Virus Infection

François Coulombe, Stéphanie Fiola, Akira Shizuo, Yvon Cormier, Jean Gosselin

PLoS ONE

Article1995

Activity of various thiocarboxanilide derivatives against wild-type and several mutant human immunodeficiency virus type 1 strains

Jan Balzarini, W G Brouwer, Ethel E. Felauer, De Clercq Erik, Anna Karlsson